Quick Answer
PETMED EXPRESS INC reported Cash and Equivalents of $54.72 million for fiscal year 2025.
PETMED EXPRESS INC Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $54.72M | -1.0% |
| 2024 | $55.30M | -46.9% |
| 2023 | $104.09M | -6.3% |
| 2022 | $111.08M | -6.4% |
| 2021 | $118.72M | +14.4% |
| 2020 | $103.76M | +3.2% |
| 2019 | $100.53M | +29.0% |
| 2018 | $77.94M | +32.7% |
| 2017 | $58.73M | +56.0% |
| 2016 | $37.64M | +5.7% |
| 2015 | $35.61M | +94.6% |
| 2014 | $18.30M | +0.8% |
| 2013 | $18.16M | -61.2% |
| 2012 | $46.80M | -5.8% |
| 2011 | $49.66M | -6.6% |
| 2010 | $53.14M | +76.4% |
| 2009 | $30.13M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $26.91M | -46.3% | -25.4% |
| September 30, 2025 | $36.10M | -30.6% | -12.2% |
| June 30, 2025 | $41.13M | -10.6% | -24.8% |
| March 31, 2025 | $54.72M | -1.0% | +9.2% |
| December 31, 2024 | $50.10M | +1.3% | -3.7% |
| September 30, 2024 | $52.05M | -2.7% | +13.2% |
| June 30, 2024 | $45.99M | -25.3% | -16.8% |
| March 31, 2024 | $55.30M | -46.9% | +11.8% |
- PETMED EXPRESS INC showed a decrease of -1.0% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2009–2025 period, PETMED EXPRESS INC’s cash and equivalents has grown by 81.6% (from $30.13 million to $54.72 million).
- The most recent figure is from PETMED EXPRESS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on October 14, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: